Bli medlem
Bli medlem

Du är här


BioStock: Erika Samuelsson new CDO at Cyxone

At the beginning of the autumn, First North-listed Cyxone announced the recruitment of Erika Samuelsson as the new Chief Development Officer with responsibility for clinical and non-clinical activities with Cyxone's drug candidates. BioStock had the opportunity to ask Erika a few questions about her background, new role and goals.

Read the interview with Cyxone's CDO Erika Samuelsson at

This is a press release from BioStock - Connecting Innovation & Capital.

Författare Cision